Advertisement
Canada markets close in 3 hours 45 minutes
  • S&P/TSX

    21,971.68
    +86.30 (+0.39%)
     
  • S&P 500

    5,102.73
    +54.31 (+1.08%)
     
  • DOW

    38,253.84
    +168.04 (+0.44%)
     
  • CAD/USD

    0.7312
    -0.0012 (-0.16%)
     
  • CRUDE OIL

    84.07
    +0.50 (+0.60%)
     
  • Bitcoin CAD

    86,851.09
    -722.70 (-0.83%)
     
  • CMC Crypto 200

    1,322.30
    -74.23 (-5.31%)
     
  • GOLD FUTURES

    2,348.10
    +5.60 (+0.24%)
     
  • RUSSELL 2000

    1,997.66
    +16.54 (+0.83%)
     
  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     
  • NASDAQ

    15,929.19
    +317.43 (+2.03%)
     
  • VOLATILITY

    15.31
    -0.06 (-0.39%)
     
  • FTSE

    8,139.83
    +60.97 (+0.75%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6837
    +0.0016 (+0.23%)
     

Germany does U-turn on AstraZeneca jab and approves its use for people aged 65 and over

 (Getty Images)
(Getty Images)

Germany has approved giving the AstraZeneca Covid-19 vaccine to people aged 65 and over.

Health minister Jens Spahn said the country's independent vaccine committee had made the decision, hailing it "good news for older people who are waiting for a vaccination”.

“They will get vaccinated faster,” he added.

The vaccine made by British-Swedish company and developed by Oxford University is one of three authorised for use in the 27-nation European Union.

But several countries, including Germany, initially restricted it to people aged under 65, or in some cases under 55, citing a lack of data on its effectiveness in older people.

ADVERTISEMENT

The policy has led to a low take-up of available doses, slowing vaccination efforts. In Germany two-thirds of 1.4 million delivered doses remained in storage on Monday.

Read More

U-turn: Germany and France set to give Oxford jab to over 65s

BitCoin blackmailer who threatened to blow up NHS hospital sentenced

Angela Merkel refuses AstraZeneca vaccine as 1.4m doses go unused